169321 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
Prognosing mortality in patients with chronic kidney disease by detecting macrophage inhibitory cytokine-1 (MIC-1)
#602Apparatus for screening cells
#603Biomarker panel for assessment of mucosal healing
#604GDF15 AS BIOMARKER FOR DIAGNOSING MITOCHONDRIAL DISEASES
#605Eye disease treatment agent, screening method therefor, and method for predicting rejection response associated with retinal pigment epithelial cell transplant
#606Compositions and methods for modulating an immune response
#607Prognostic and Diagnostic Methods and Herbal Therapies for Treating Skin Conditions, Autoimmune Diseases, Inflammatory Ailments and Cancer
#608Small molecule TRAIL gene induction by normal and tumor cells as an anticancer therapy
#609T cell balance gene expression, compositions of matters and methods of use thereof
#610METHOD FOR PREDICTING THERAPEUTIC EFFECT OF BIOLOGICAL PREPARATION ON RHEUMATOID ARTHRITIS
#611LKB1 related diagnostics and treatments of cancer
#612Blockade of CCL18 signaling via CCR6 as a therapeutic option in treating interstitial lung disease
#613Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
#614Anti-OX40 antibodies
#615SRM/MRM assay for the fibroblast growth factor receptor 2 (FGFR2) protein
#616Method and means for diagnosing and treating allergy
#617Anti-MIF immunohistochemistry
#618Antibodies against TL1a and uses thereof
#619TH17 DIFFERENTIATION MARKERS FOR ACNE AND USES THEREOF
#620Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of CXCL9 and other biomarkers
#621Use of miR-494 to Modulate TRAIL-induced Apoptosis through BIM Down-regulation
#622Bacterial compositions and methods of use thereof for treatment of immune system disorders
#623MRM/SRM assay for death receptor 5 protein
#624Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors
#625ELEVATED CCL19 AFTER COMPLETION OF THERAPY FOR ACUTE LYME DISEASE IDENTIFIES PATIENTS AT RISK FOR DEVELOPMENT OF POST-TREATMENT LYME DISEASE SYNDROME WHO WILL BENEFIT FROM FURTHER ANTIBIOTIC THERAPY
#626METHODS FOR DIAGNOSING, SCREENING, IDENTIFYING, MONITORING, AND TREATING ADVERSE LOCAL TISSUE REACTIONS, WHICH LEAD TO FAILURE OF ORTHOPEDIC IMPLANTS
#627Liver tissue culturing device, liver tissue culturing system, liver tissue culturing method, and liver function evaluation method
#628Magnetic bead-based digital microfluidic immunoanalysis device and method thereof
#629TNF-ALPHA BINDING PROTEINS
#630Relevance of achieved levels of markers of systemic inflammation following treatment
#631Water soluble membrane proteins and methods for the preparation and use thereof
#632Anti-alphavbeta1 integrin inhibitors and methods of use
#633Antibodies that inhibit long interspersed element-1 retrotransposon endonuclease activity
#634METHODS FOR PREVENTION AND TREATMENT OF INFLAMMATION USING ANTI-CHEMOKINE ANTIBODIES
#635Biomarkers related to organ function
#636Method of treating or improving neurological function in a human subject
#637Isolated B7-H4 specific compositions and methods of use thereof
#638Signature of TL1A (TNFSF15) signaling pathway
#639Proliferation-inducing ligand (APRIL)-binding peptides
#640ANTI-INFLAMMATORY COMPOSITIONS, METHODS AND USES THEREOF
#641Suppression of cytokine release and cytokine storm
#642Anti-C5 antibodies
#643Simultaneous Assay of Target and Target-Drug Binding
#644STRESS AND INFLAMMATION BIOMARKER URINE PANEL FOR DAIRY COWS AND BEEF CATTLE
#645Antibody and Cytokine Biomarker Profiling for Determination of Patient Responsiveness
#646Biomarker for psychiatric and neurological disorders
#647Anti-nodal antibodies and methods of using same
#648ERYTHROFERRONE AND ERFE POLYPEPTIDES AND METHODS OF REGULATING IRON METABOLISM
#649Systems and methods for characterizing kidney diseases
#650Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo
#651Anti-CXCL1, CXCL7 and CXCL8 antibodies and their applications
#652Carbohydrate Compounds for Nutritional and Therapeutic Use
#653Glatiramer acetate human monocytic cell line-based potency assay
#654Assay for determining endogenous levels of analyte in vivo
#655PERSONALISED MEDICINE
#656Diagnostic biomarker to predict women at risk for preterm delivery
#657Anti-ectodysplasin antibodies
#658Methods for determining responsiveness to an anti-CD47 agent
#659FUTURE CARDIAC EVENT BIOMARKERS
#660Nanoelectronic-enzyme linked immunosorbent assay system and method
#661Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies
#662Kit for predicting implantation success in assisted fertilization
#663Neutralizing anti-CCL20 antibodies
#664Parasitic biological agents for treatment and prevention of graft versus host disease
#665CCL22 and CCL17 cancer biomarkers
#666B7-H4 fusion proteins and methods of use thereof
#667Method for identifying a bacterial infection
#668Human antibody specific for interleukin-1alpha
#669Quantification of misfolded TNFR2:Fc
#670SALIVARY BIOASSAY FOR EARLY DETECTION OF BONE LOSS
#671BIOMARKERS FOR INFLAMMATORY DISEASE AND METHODS OF USING SAME
#672Methods of diagnosing, treating and monitoring diabetic retinopathy
#673Systems and methods for collecting tear film and measuring tear film osmolarity
#674Bispecific antibodies against CD3 and BCMA
#675Method for the selection of antibodies against BCMA
#676Method for Differentiating Sepsis and Systemic Inflammatory Response Syndrome (SIRS)
#677Treatment of inflammation using alpha 7 receptor-binding agonists
#678METHOD FOR OBTAINING DATA THAT ARE USEFUL FOR THE DIAGNOSIS, PROGNOSIS AND CLASSIFICATION OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND/OR LUNG CANCER
#679Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#680Biomarkers in inflammatory bowel disease
#681Human CDR-grafted antibody and antibody fragment thereof
#682METHODS AND KITS FOR DETECTING ANTIGEN-INDUCED MEMORY CD8+ T CELLS
#683Use of common γ chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytes
#684Salivary inflammatory biomarkers associated with glycemic control and oral health
#685Method for diagnosing fibromyalgia
#686METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF SEPSIS
#687Serological markers of inflammatory bowel disease phenotype and disease progression
#688Compositions and methods relating to lyme disease
#689Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#690Methods for detecting antibodies
#691METHOD AND APPARATUS FOR DETERMINING A MAMMAL'S EXPOSURE TO CHEMICAL OR BIOLOGICAL AGENTS
#692Small molecule TRAIL gene induction by normal and tumor cells as an anticancer therapy
#693Methods and kits for predicting a response to an erythropoietic agent
#694VAGUS NERVE STIMULATION SCREENING TEST
#695Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
#696COMPOSITIONS AND METHODS OF PROGNOSIS AND CLASSIFICATION FOR RECOVERY FROM SURGICAL TRAUMA
#697Methods for detecting heparin/platelet factor 4 antibodies
#698Use of miR-494 to modulate TRAIL-induced apoptosis through BIM down-regulation
#699Target peptides for immunotherapy and diagnostics
#700Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
#701BIOMARKERS FOR DIAGNOSING AND/OR MONITORING TUBERCULOSIS
#702Composition comprising material for inhibiting SCF or receptor thereof for treating or preventing diseases associated with vascular permeability
#703Biomarker of renal dysfunction
#704Diagnostic and screening methods for atopic dermatitis
#705DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#706Inhibitors of the CD95 signaling pathway for treatment of MDS
#707Anti-MIF immunohistochemistry
#708Compositions comprising antibodies targeting factor P
#709METHODS FOR DIAGNOSING OSTEOARTHRITIS
#710Human T cell line assay for evaluating the immunologic identity of glatiramer acetate preparations
#711Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof
#712Biomarker of renal dysfunction
#713METHODS FOR DECONTAMINATING CIRCUITS FOR PRODUCING GLUCOSE POLYMERS AND HYDROLYSATES OF GLUCOSE POLYMERS
#714Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury
#715Genetically modified non-human animals and methods relating to innate immune system response detection
#716Human monoclonal antibodies to CTLA-4
#717Biomarkers
#718In-vitro process for the quick determination of a patient's status relating to infection with
#719Biomarkers for Systemic Lupus Erythematosus Disease Activity, and Intensity and Flare
#720SYSTEM, AN APPARATUS AND A COMPUTER PROGRAM PRODUCT FOR OBTAINING AN INFORMATION RELATED TO EOSINOPHILIC AIRWAY INFLAMMATION
#721Device and method for detection of analytes
#722Diagnostic devices, methods and systems for detecting platelet factor 4 (PF4)/heparin antibodies
#723ENDOTHELIAL-MONOCYTE ACTIVATING POLYPEPTIDE II (EMAP-II), A BIOMARKER FOR USE IN DIAGNOSIS AND TREATMENT OF BRAIN INJURY
#724DIAGNOSIS AND TREATMENT OF TRAUMATIC BRAIN INJURY
#725Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#726Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens
#727Signatures and determinants for diagnosing infections and methods of use thereof
#728METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR
#729PULMONARY HYPERTENSION
#730METHODS AND DEVICES FOR CLASSIFYING AND MANAGING AUTOIMMUNE AND INFLAMMATORY CONDITIONS
#731BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUADROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS
#732Multiplexed assay kit to evaluate the efficacy of treatment for inflammatory bowel disease
#733Angiogenin for treatment of glaucoma
#734Biomarkers for Tuberculosis and HIV/AIDS
#735TUMOR-SPECIFIC GM-CSF CYTOKINE RESPONSE AS PREDICTOR OF CANCER VACCINE EFFECTIVENESS
#736Simultaneous Assay of Target and Target-Drug Binding
#737Tools and methods for expression of membrane proteins
#738NEW TH-17 DIFFERENTIATION MARKERS FOR ROSACEA AND USES THEREOF
#739Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
#740High throughput sensitization detection devices and methods
#741METHOD FOR DIAGNOSING AND TREATING FIBROMYALGIA
#742Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
#743NEW LEUKOCYTE INFILTRATE MARKERS FOR ROSACEA AND USES THEREOF
#744Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
#745Isolated B7-H4 specific compositions and methods of use thereof
#746Biomarkers for TSLP treatment
#747Use of RANK/RANKL antagonists for treating muscular dystrophy
#748Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
#749Isolated B7-H4 specific compositions and methods of use thereof
#750Use of tumor Fas expression to determine response to anti-cancer therapy
#751Characterization of CHO-MIF gene and protein, and use thereof
#752Methods of evaluating BAFF
#753Cystine knot peptides that bind alpha-V-beta-6 integrin
#754Dual Specific Binding Proteins Directed Against TNF
#755PLASMONIC SUBSTRATES FOR METAL-ENHANCED FLUORESCENCE BASED SENSING, IMAGING AND ASSAYS
#756ANTIBODIES AGAINST TL1a AND USES THEREOF
#757Multiplexed analyses of test samples
#758OxMIF as a diagnostic marker
#759Method for diagnosis, prognosis or treatment of acute coronary syndrome (ACS) comprising measurement of plasma concentration of macrophage migration inhibitory factor (MIF)
#760Method and reagent for diagnosis and/or evaluation of progression of graft-versus-host disease
#761METHOD OF TREATING MULTIPLE SCLEROSIS BY INTRATHECAL DEPLETION OF B CELLS AND BIOMARKERS TO SELECT PATIENTS WITH PROGRESSIVE MULTIPLE SCLEROSIS
#762Methods of treating pancreatitis
#763TH17 DIFFERENTIATION MARKERS FOR ACNE AND USES THEREOF
#764HIGH-THROUGHPUT ASSESSMENT METHOD FOR CONTACT HYPERSENSITIVITY
#765MRM/SRM assay for death receptor 5 protein
#766MACROPHAGE INHIBITORY CYTOKINE-1 (MIC-1) AS A PROGNOSTIC MARKER IN CHRONIC KIDNEY DISEASE
#767ANTI-TNF AND ANTI-IL 17 COMBINATION THERAPY BIOMARKERS FOR INFLAMMATORY DISEASE
#768ANTI-INFLAMMATORY FOOD PRODUCT
#769Method to screen for an activator of adipose-resident NK cells
#770Human CDR-grafted antibody and antibody fragment thereof
#771Method of inhibiting binding or activity of MIF by administering a MIF antagonist
#772Human resistin receptor and use thereof
#773Method of assessing infection status
#774CYTOKINE PROFILES AS METHODS FOR DIAGNOSIS AND PROGNOSIS OF IRRITABLE BOWEL SYNDROME
#775Antigen presenting cell targeted anti-viral vaccines
#776Methods for treatment of age-related macular degeneration
#777Biomarkers of immunotherapy efficacy
#778Modulators of Plexin B2 activity
#779Human monoclonal antibodies to CTLA-4
#780Assay method for peptide specific T-cells
#781IMMUNE FUNCTION BIOMARKERS
#782Human exhaled aerosol droplet biomarker system and method
#783Method of Using Cytokine Assays to Diagnose, Treat, and Evaluate Inflammatory Disease
#784Methods for differentiating between disease states
#785Levels of BLyS/APRIL heterotrimers in serum and use in diagnostic methods
#786Agents and methods related to screening for resistance to DR5 and reducing resistance to DR5 agonists
#787Assessment and reduction of risk of graft-versus-host disease
#788Methods of Diagnosing and Treating an Inflammatory Response
#789USING A CYTOKINE SIGNATURE TO DIAGNOSE DISEASE OR INFECTION
#790METHODS FOR DIAGNOSIS AND PROGNOSIS OF INFLAMMATORY BOWEL DISEASE USING CYTOKINE PROFILES
#791DIAGNOSTIC TESTS FOR IMMUNE REACTIVITY WITH HUMAN ENDOTHELIAL CELL GROWTH FACTOR
#792ANTIBODIES AGAINST A PROLIFERATING INDUCING LIGAND (APRIL)
#793Antibodies that bind factor P
#794Use of VEGF-C agonists for inhibiting ultraviolet B-induced skin damage
#795Antibodies against a proliferating inducing ligand (APRIL) and methods of use thereof
#796Human CDR-grafted antibody and antibody fragment thereof
#797METHOD AND REAGENT FOR DIAGNOSIS AND/OR EVALUATION OF PROGRESSION OF GRAFT-VERSUS-HOST DISEASE
#798Function homology screening
#799Methods and Compositions for Highly Sensitive Detection of Molecules
#800Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 and uses thereof
#801METHODS FOR DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISORDERS MEDIATED BY CD40 SIGNALING
#802Nucleic acids encoding antibody 137-26 which binds C5 and C5a
#803SPECIFIC REGULATION OF CYTOKINE LEVELS BY HDAC6 INHIBITORS
#804Methods of diagnosing pancreatic inflammation by using chemokine PANEC-1 antibodies
#805METHODS OF DETERMINING EFFICACY OF TREATMENTS OF DISEASES OF THE BOWEL
#806Multiplex Immune Effector Molecule Assay
#807Human G-protein chemokine receptor HSATU68
#808BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUADROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS
#809Methods of evaluating BAFF
#810NOVEL MODULATORS OF TRAIL SIGNALLING
#811CD40L-binding agent based platelet aggregation assays
#812Biomechanical-based methods of diagnosing scoliosis
#813DIAGNOSTIC TEST
#814METHODS OF PROGNOSIS AND DIAGNOSIS OF RHEUMATOID ARTHRITIS
#815METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#816Immunobinders directed against TNF
#817Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#818METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#819MODULATION OF CYTOKINE-INDUCED CHRONIC INFLAMMATORY RESPONSES
#820IN VITRO PROCESS FOR THE QUICK DETERMAINATION OF A PATIENT'S STATUS RELATING TO INFECTION WITH MYCOBACTERIUM TUBERCULOSIS
#821Compositions and methods for diagnosis, prognosis and management of malaria
#822CXCL5 AS A MARKER OF HORMONE ESCAPE IN PROSTATE CANCER
#823BCMA-BASED STRATIFICATION AND THERAPY FOR MULTIPLE MYELOMA PATIENTS
#824Cytokines and Genes Differentially Affected by TNF Blockers
#825Method of identifying transmembrane protein-interacting compounds
#826GDF-15 BASED MEANS AND METHODS FOR SURVIVAL AND RECOVERY PREDICTION IN ACUTE INFLAMMATION
#827DENTINAL DRUG DELIVERY COMPOSITION AND SCREENING METHOD
#828METHOD AND REAGENT FOR DIAGNOSIS AND/OR EVALUATION OF PROGRESSION OF GRAFT-VERSUS-HOST DISEASE
#829RANTES Multiplexed Assay, RANTES Variants Related to Disease, and RANTES Variants Related to Enzymatice Activity
#830Chimeric Receptors and Methods for Identifying Agents Exhibiting an Activity on Type 1 Single Pass Transmembrane Receptors
#831Therapeutic Inhibition of Granulocyte Function in Demyelinating Disease
#832Genes predictive of anti-TNF response in inflammatory diseases
#833Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrow
#834Method and Apparatus for Determining a Mammal's Exposure to Chemical or Biological Agents
#835Molecular determinants in the HIV-1 envelope associated with enhanced ability to enter CXCR4-expressing cells
#836Subcutaneously administrable composition containing anti-IL-6 antibody
#837Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity
#838Salivary Bioassay for Early Detection of Bone Loss
#839Compositions and methods for diagnosis, prognosis and management of malaria
#840Epidermal Growth Factor Receptor (EGFR) Protein SRM Assay
#841METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#842Methods for prevention and treatment of inflammation using anti-chemokine antibodies
#843METHODS OF DIAGNOSING AND PROGNOSING COLONIC POLYPS
#844Anti-C5/C5a antibodies and methods of use
#845COMPOSITION AND METHOD FOR ANALYSIS OF TARGET ANALYTES
#846ANTAGONISTS OF IL-6 TO RAISE ALBUMIN AND/OR LOWER CRP
#847Antagonists of IL-6 to prevent or treat thrombosis
#848Kit for predicting implantation success in assisted fertilization
#849Inhibition of the interaction between 5T4 oncofoetal glycoproteins and CXC chemokine receptors as a method of identifying chemotaxis inhibitors
#850B7-H4 fusion proteins and methods of use thereof
#851Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
#852METHOD OF USING CYTOKINE ASSAYS TO DIAGNOSE, TREAT, AND EVALUATE INFLAMMATORY AND AUTOIMMUNE DISEASES
#853METHOD OF DETERMINING THE NUCLEOTIDE SEQUENCE OF OLIGONUCLEOTIDES AND DNA MOLECULES
#854Water soluble membrane proteins and methods for the preparation and use thereof
#855GDF-15 and/or Troponin T for Predicting Kidney Failure in Heart Surgery Patients
#856RANTES LEVELS AS A DIAGNOSTIC AND THERAPEUTIC FOR ACUTE GRAFT VERSUS HOST DISEASE
#857METHOD AND SYSTEM TO DETECT AND DIAGNOSE ALZHEIMER'S DISEASE
#858Methods of evaluating BAFF
#859TNF-α binding proteins
#860DIAGNOSTIC METHOD FOR DETECTING CANCER BY MEASURING AMOUNT OF A CYTOKINE LIKE IL-6
#861HMGB1 binding nucleic acid molecule and applications thereof
#862ASSESSING RHEUMATOID ARTHRITIS
#863Systems and methods for characterizing kidney diseases
#864BIOMARKERS FOR IAP INHIBITOR COMPOUNDS
#865Therapeutic Use of Farnesyltransferase Inhibitors and Methods of Monitoring the Efficacy Thereof
#866NOVEL ASSAY FOR DETECTING IMMUNE RESPONSES INVOLVING ANTIGEN SPECIFIC CYTOKINE AND/OR ANTIGEN SPECIFIC CYTOKINE SECRETING T-CELLS
#867Antibodies against a proliferating inducing ligand (APRIL) and methods of use thereof
#868Method for diagnosing and treating emphysema
#869Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
#870Serum Markers Predicting Clinical Response to Anti-TNF Alpha Antibodies in Patients with Psoriatic Arthritis
#871METHODS OF TREATMENT USING AN ANTI IL B50 ANTIBODY
#872Methods and compositions for the inhibition of transplant rejection
#873HUMAN CDR-GRAFTED ANTIBODY AND ANTIBODY FRAGMENT THEREOF
#874Methods and compositions for diagnostic assays for measuring cell mediated immune response
#875Elisa for a naturally-occurring soluble truncated form of IL-23 receptor
#876METHODS OF USING sIP-10, CD26 INHIBITORS AND CXCR3 LEVELS IN A SAMPLE TO ASSESS CLEARANCE OF INFECTION, RESPONSE TO INTERFERON THERAPY, AND TREATING CHRONIC INFECTIONS
#877Uses of CD116 Expression Level
#878Interleukin-1 Alpha Antibodies and Methods of Use
#879Injection mould having a varying volume mould cavity
#880Methods of treating cancer with human monoclonal antibodies to CTLA-4
#881Neutralizing anti-CCL20 antibodies
#882Immunomodulation of functional T cell assays for diagnosis of infectious or autoimmune disorders
#883Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists
#884Use of lymphocytes to measure anthrax lethal toxin activity
#885HOMEOSTATIC MULTIDOMAIN PROTEIN, AND USES FOR IT
#886Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate
#887Method for detection of active periodontal disease at the local tooth site
#888METHODS OF PROGNOSIS IN CHRONIC KIDNEY DISEASE
#889Method of Predicting Placebo Non-Response
#890Novel Receptor Hetero-Dimers/-Oligomers
#891METHODS FOR CREATING OR IDENTIFYING COMPOUNDS THAT BIND TUMOR NECROSIS FACTOR ALPHA
#892Immunological method for detecting active JCV infection
#893Systems and methods for collecting tear film and measuring tear film osmolarity
#894THERAPEUTICS FOR AGE-RELATED MACULAR DEGENERATION
#895Biomarkers for differentiating between type 1 and type 2 diabetes
#896Method and kit for establishing an in vitro prognosis on a patient exhibiting SIRS
#897Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
#898Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
#899Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signaling
#900BIOMARKERS